The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERATE DIAGNOSTICS INC | NOTE 5.000%12/1 | 00430HAC6 | 18,524,650 | 37,049,299 | PRN | SOLE | 37,049,299 | 0 | 0 | |||
| ADVANTAGE SOLUTIONS INC | COM CL A | 00791N102 | 1,481,106 | 980,865 | SH | SOLE | 980,865 | 0 | 0 | |||
| ATLANTA BRAVES HLDGS INC | COM SER C | 047726302 | 3,753,378 | 93,811 | SH | SOLE | 93,811 | 0 | 0 | |||
| BANDWIDTH INC | NOTE 0.500% 4/0 | 05988JAD5 | 32,481,750 | 40,250,000 | PRN | SOLE | 40,250,000 | 0 | 0 | |||
| BLACKBAUD INC | COM | 09227Q100 | 11,975,650 | 193,000 | SH | SOLE | 193,000 | 0 | 0 | |||
| EMBECTA CORP | COMMON STOCK | 29082K105 | 2,829,710 | 221,938 | SH | SOLE | 221,938 | 0 | 0 | |||
| EQUITY COMWLTH | COM SH BEN INT | 294628102 | 13,529,492 | 8,403,411 | SH | SOLE | 8,403,411 | 0 | 0 | |||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 4,320,000 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | |||
| IRONWOOD PHARMACEUTICALS INC | NOTE 1.500% 6/1 | 46333XAH1 | 15,080,700 | 17,000,000 | PRN | SOLE | 17,000,000 | 0 | 0 | |||
| ON24 INC | COM | 68339B104 | 22,049,331 | 4,240,256 | SH | SOLE | 4,240,256 | 0 | 0 | |||
| SUMMIT HOTEL PPTYS | NOTE 1.500% 2/1 | 866082AA8 | 27,793,227 | 29,039,000 | PRN | SOLE | 29,039,000 | 0 | 0 | |||
| TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | 12,780,300 | 13,000,000 | PRN | SOLE | 13,000,000 | 0 | 0 | |||